
The AU480 clinical chemistry anaylser
Olympus will present the latest member of its clinical chemistry analyser family at Medica.

Olympus will present the latest member of its clinical chemistry analyser family at Medica.
Siemens new Clinitek Micro-albumin 9 Urinalysis Strip is now available in Europe. The strips, which can be used on the firm's Clinitek Status analyser, or the Clinitek Advantus analyser, provide nine tests to detect and monitor kidney disease.
The French firm bioMérieux and ProteoSys, based in Mainz, Germany, have signed a license and development agreement for Annexin 3 to be used to develop a urine-based, confirmatory diagnostic test for prostate cancer.

Injections, that's everyday business for the men and women working in healthcare. As long as it is the patients who have to face the needle, it seems. Like in the years before Dr Heinzpeter Moecke, medical director of Asklepios Klinik Nord-Heidberg in Hamburg, Germany, set an example for his staff and had a vaccination.

GenoType® MTBDR plus, a new molecular test for multidrug-resistant tuberculosis has recently been approved in Europe. The test, developed by the Foundation for Innovative New Diagnostics (FIND) and Hain Lifescience, offers a fast solution to detect MDR-TB and XDR-TB at a reasonable price, a good condition for the application in poorer countries.

Good news for diabetes patients in the UK: According to a report published recently by the Department of Health, diabetes care in the NHS is improving and focusing more on prevention. The result: More patients have been identified, and in more people at risk development of the condition could be prevented.

The Clinical and Laboratory Standards Institute (CLSI) recently published new guidelines which offer methods to assess test performance when formal proficiency testing programs are not available. Proficiency testing is an important part of quality management in the clinical laboratory and complements internal quality control to help ensure patient test results are valid.
Bayer HealthCare Diabetes Care unveiled the new CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Last week the English government closed its consultation on the effectiveness of vascular checks for high-risk people aged 40-74. Would this help? Experts from New Zealand and the WHO say "yes". Others argue that public health approaches targeting the whole population are both: cheaper and more effective than tablets.

Vulvar cancer is the fourth most common cancer of the female genital tract. In 2008, roughly 3,460 cases of vulvar cancer will be diagnosed in the United States and about 870 will die of this cancer, according to the American Cancer Society.
Two Dutch studies indicate that especially somatic and incident depressions are associated with poor prognosis in cardiac patients, which is very different from the 'typical' psychiatric depression that is usually characterised by cognitive and recurrent depressive symtoms.
Professor C Mueller adressed the issue of new biomarkers in acute cardiac care on the ESC on Monday, 1st September. Read his comment in the following.

In the next 10-20 years, great changes will occur in the field of laboratory medicine.
During the XVII International AIDS Conference held in Mexico City this August, keynote speakers from Europe, Latin America and Africa addressed issues including the importance of early detection of HIV infection, the relevance of rapid testing for epidemiology studies, the use of Dried Blood Spots for routine viral-load testing in remote areas, and the experience of South Africa in routine…


The new Contour blood glucose meter from Bayer HealthCare Diabetes Care promises enhanced testing features that can be personalised to meet diabetics individual treatments. The firm has also redesigned the Microlet 2 lancing system.

Roche reports that, using its NimbleGen CGH arrays, researchers* have identified a recurrent reciprocal genomic rearrangement of chromosomal region 17q12 in foetal samples with congenital anomalies that is also associated with paediatric renal disease and epilepsy.
Researchers funded by the European Union have devised OptoLabCard, a system that prepares samples and performs DNA tests on bacteria in a portable, easily used, cost-effective lab-on-a-chip.

Unlike regular laboratory analyses, which is performed by clinical pathologists and technicians in the clinical laboratory, Point of Care Testing (POCT) are devices to perform laboratory analyses in the vicinity of the patient by the attending physician or nurses.

Hunt Biobank, Norway's biggest research biobank, is using Thermo Fisher Scientific Inc's Nautilus LIMS in its HUNT 3 study, to gather, store, manage, track and retrieve the biological data of approximately 100,000 people from Nord-Trøndelag County.

First emerging at the beginning of the '60s, Methicillin-resistant Staphylococcus aureus as a nosocomial infection - healthcare associated MRSA (haMRSA) - has become an increasingly prevalent infection control problem in many countries.
The world's first symposium on the molecular analysis of sudden death syndrome (SDS) among athletes drew in leading cardiovascular researchers and several top Spanish footballers. Sponsored by Applied Biosystems, and held in the Madrid's Hospital Clinico San Carolos, the I Symposium de Prevención en el Futbol aims to initiate the development of new tests to identify sports players at SDS risk.

Countries vary widely in their capacity to manage hypertension, but globally the majority of diagnosed hypertensives is inadequately controlled. Not treated it can cause cardiovascular disease (CVD), myocardial infarction and stroke. According to the WHO, hypertension is estimated to cause 4.5% of the current global disease burden and is as prevalent in many developing countries as in the…

The probability of woman of suffering from cardiovascular diseases is often underestimated. A recent study evaluated the risk of nearly 9.000 women in the U.S. screened for heart-health risk: one in five women had a higher risk than measured by a frequently used predictor.

bioMérieux developed three new microbiology laboratory automation platforms: Two new lab automatic tools and the the UF-1000i, a urinary screening tool to accurately detect and enumerate the bacteria and particles presented in urine specimens.